Although DUX4 upregulation is thought to be the pathogenic cause of FSHD, DUX4 is lowly expressed in patient samples, and analysis of the consequences of DUX4 expression has largely relied on artificial overexpression. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.